Are you Dr. Fetting?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 124 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10803 Falls Road
Pavilion Iii Ste 1500
Lutherville, MD 21093Phone+1 410-583-2970Fax+1 410-583-2980
Summary
- Dr. John Fetting, MD is an oncologist in Lutherville, Maryland. He is currently licensed to practice medicine in Maryland. He is affiliated with Johns Hopkins Hospital and is an Associate Professor of Oncology at Assistant Professor of Psychiatry and Behavioral Sciences.
Education & Training
- Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1977 - 1980
- Johns Hopkins UniversityResidency, Internal Medicine, 1975 - 1977
- Johns Hopkins University School of MedicineClass of 1975
Certifications & Licensure
- MD State Medical License 1975 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Top MD Consumers Checkbook
Clinical Trials
- Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer Start of enrollment: 2014 Jan 16
Publications & Presentations
PubMed
- 191 citationsDoctor-patient communication about breast cancer adjuvant therapyLaura A. Siminoff, J H Fetting, M D Abeloff
Journal of Clinical Oncology. 1989-09-01 - 247 citationsDetection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral BloodMichaela J. Higgins, Danijela Jelovac, Evan Barnathan, Brian G. Blair, Shannon Slater
Clinical Cancer Research. 2012-06-15 - 50 citationsTBCRC 008: Early Change in 18F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operab...Roisin M. Connolly, Jeffrey P. Leal, Matthew P. Goetz, Zhe Zhang, Xian C. Zhou
Journal of Nuclear Medicine. 2015-01-01
Grant Support
- Clinical OncologyNational Cancer Institute1994–1996
- Clinical Oncology Research Career Development ProgramNational Cancer Institute1993
Professional Memberships
- Member